📰 Numinus Bioscience News
Page 8 - Numinus Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Numinus Bioscience. Real-time updates on events, politics, business and more.
December 16, 2021
/PRNewswire/ -- Drugs like ketamine and psilocybin — the active ingredient in magic mushrooms — are showing real promise in addressing mental health disorders....
December 10, 2021
"During the fourth quarter we were focused on building the team, infrastructure, technologies and protocols that will allow us to scale our...
December 9, 2021
Ended the year with strong cash position of $59.2 million Revenues grew 81% year-over-year to $0.5 million for Q4 2021 Revenues grew 72% year-over-year to $1.5...
December 9, 2021
Ended the year with strong cash position of $59.2 million Revenues grew 81% year-over-year to $0.5 million for Q4 2021 Revenues grew 72% year-over-year to $1.5...
November 29, 2021
/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a leader in psychedelics-focused mental healthcare, has today announced novel,...
November 29, 2021
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
November 29, 2021
"The testing weve developed and validated at Numinus Bioscience will facilitate the safety and efficacy testing of psychedelics for our...
November 4, 2021
- FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Nov. 4, 2021 /PRNewswire/ -- The pace of society's change in attitude to the use of psychedelics has been amazing. It has gone
October 28, 2021
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future...